Dynamics of gene expression during bone matrix formation in osteogenic cultures derived from human embryonic stem cells in vitro

Biochimica et Biophysica Acta - General Subjects

Volumn 1790, Issue 2, 2009, Pages 110-118

  Kärner, Elerin ^a   Bäckesjö, Carl Magnus ^a   Cedervall, Jessica ^b   Sugars, Rachael V ^a   Ährlund Richter, Lars ^b   Wendel, Mikael ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Differentiation; Embryonic stem cell; Extracellular matrix; Gene expression; Osteogenesis

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 1; OSTEOCALCIN; OSTEOPONTIN; SIALOPROTEIN; TRANSCRIPTION FACTOR OSTERIX; VASCULOTROPIN;

ARTICLE; BONE MATRIX; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MOLECULAR MODEL; OSSIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; STEM CELL; UPREGULATION;

ASCORBIC ACID; BONE MATRIX; BONE MORPHOGENETIC PROTEIN 2; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DEXAMETHASONE; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION; GLYCEROPHOSPHATES; HUMANS; MODELS, BIOLOGICAL; OSTEOGENESIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 58149199688     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2008.10.004     Document Type: Article

References (75)

1. Ecarot-Charrier B., Glorieux F.H., van der Rest M., and Pereira G. Osteoblasts isolated from mouse calvaria initiate matrix mineralization in culture. J. Cell Biol. 96 (1983) 639-643
2. Whitson S.W., Harrison W., Dunlap M.K., Bowers Jr. D.E., Fisher L.W., Robey P.G., and Termine J.D. Fetal bovine bone cells synthesize bone-specific matrix proteins. J. Cell Biol. 99 (1984) 607-614
3. Schmidt J., Strauss G.P., Schon A., Luz A., Murray A.B., Melchiori A., Aresu O., and Erfle V. Establishment and characterization of osteogenic cell lines from a spontaneous murine osteosarcoma. Differentiation 39 (1988) 151-160
4. Friedenstein A.J., Piatetzky II S., and Petrakova K.V. Osteogenesis in transplants of bone marrow cells. J. Embryol. Exp. Morphol. 16 (1966) 381-390
5. Thomas D.M., Johnson S.A., Sims N.A., Trivett M.K., Slavin J.L., Rubin B.P., Waring P., McArthur G.A., Walkley C.R., Holloway A.J., Diyagama D., Grim J.E., Clurman B.E., Bowtell D.D., Lee J.S., Gutierrez G.M., Piscopo D.M., Carty S.A., and Hinds P.W. Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma. J. Cell Biol. 167 (2004) 925-934
6. Bellows C.G., Aubin J.E., Heersche J.N., and Antosz M.E. Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif. Tissue Int. 38 (1986) 143-154
7. Aubin J.E. Regulation of osteoblast formation and function. Rev. Endocr. Metab. Disord. 2 (2001) 81-94
8. Aubin J.E. Advances in the osteoblast lineage. Biochem. Cell. Biol. 76 (1998) 899-910
9. Wang L.L. Biology of osteogenic sarcoma. Cancer J. 11 (2005) 294-305
10. Buttery L.D., Bourne S., Xynos J.D., Wood H., Hughes F.J., Hughes S.P., Episkopou V., and Polak J.M. Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells. Tissue Eng. 7 (2001) 89-99
11. Bielby R.C., Boccaccini A.R., Polak J.M., and Buttery L.D. In vitro differentiation and in vivo mineralization of osteogenic cells derived from human embryonic stem cells. Tissue Eng. 10 (2004) 1518-1525
12. Sottile V., Thomson A., and McWhir J. In vitro osteogenic differentiation of human ES cells. Cloning Stem Cells 5 (2003) 149-155
13. zur Nieden N.I., Kempka G., and Ahr H.J. In vitro differentiation of embryonic stem cells into mineralized osteoblasts. Differentiation 71 (2003) 18-27
14. Karner E., Unger C., Sloan A.J., Ahrlund-Richter L., Sugars R.V., and Wendel M. Bone matrix formation in osteogenic cultures derived from human embryonic stem cells in vitro. Stem Cells Dev. 16 (2007) 39-52
15. Karp J.M., Ferreira L.S., Khademhosseini A., Kwon A.H., Yeh J., and Langer R.S. Cultivation of human embryonic stem cells without the embryoid body step enhances osteogenesis in vitro. Stem Cells (Dayton, Ohio) 24 (2006) 835-843
16. Cao T., Heng B.C., Ye C.P., Liu H., Toh W.S., Robson P., Li P., Hong Y.H., and Stanton L.W. Osteogenic differentiation within intact human embryoid bodies result in a marked increase in osteocalcin secretion after 12 days of in vitro culture, and formation of morphologically distinct nodule-like structures. Tissue Cell 37 (2005) 325-334
17. Duplomb L., Dagouassat M., Jourdon P., and Heymann D. Differentiation of osteoblasts from mouse embryonic stem cells without generation of embryoid body. In Vitro Cell. Dev. Biol. 43 (2007) 21-24
18. Ahn S.E., Kim S., Park K.H., Moon S.H., Lee H.J., Kim G.J., Lee Y.J., Park K.H., Cha K.Y., and Chung H.M. Primary bone-derived cells induce osteogenic differentiation without exogenous factors in human embryonic stem cells. Biochem. Biophys. Res. Commun. 340 (2006) 403-408
19. Ryoo H.M., Lee M.H., and Kim Y.J. Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells. Gene 366 (2006) 51-57
20. zur Nieden N.I., Kempka G., Rancourt D.E., and Ahr H.J. Induction of chondro-, osteo- and adipogenesis in embryonic stem cells by bone morphogenetic protein-2: effect of cofactors on differentiating lineages. BMC Dev. Biol. 5 (2005) 1
21. zur Nieden N.I., Price F.D., Davis L.A., Everitt R.E., and Rancourt D.E. Gene profiling on mixed embryonic stem cell populations reveals a biphasic role for beta-catenin in osteogenic differentiation. Mol. Endocrinol. 21 (2007) 674-685
22. Hanada K., Dennis J.E., and Caplan A.I. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J. Bone Miner. Res. 12 (1997) 1606-1614
23. Pal R., and Khanna A. Similar pattern in cardiac differentiation of human embryonic stem cell lines, BG01V and ReliCellhES1, under low serum concentration supplemented with bone morphogenetic protein-2. Differentiation 75 (2007) 112-122
24. Pera M.F., Andrade J., Houssami S., Reubinoff B., Trounson A., Stanley E.G., Ward-van Oostwaard D., and Mummery C. Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin. J. Cell Sci. 117 (2004) 1269-1280
25. Deckers M.M., Karperien M., van der Bent C., Yamashita T., Papapoulos S.E., and Lowik C.W. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 141 (2000) 1667-1674
26. Villanueva J.E., and Nimni M.E. Promotion of calvarial cell osteogenesis by endothelial cells. J. Bone Miner. Res. 5 (1990) 733-739
27. Deckers M.M., van Bezooijen R.L., van der Horst G., Hoogendam J., van Der Bent C., Papapoulos S.E., and Lowik C.W. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 143 (2002) 1545-1553
28. Imreh M.P., Gertow K., Cedervall J., Unger C., Holmberg K., Szoke K., Csoregh L., Fried G., Dilber S., Blennow E., and Ahrlund-Richter L. In vitro culture conditions favoring selection of chromosomal abnormalities in human ES cells. J. Cell. Biochem. 99 (2006) 508-516
29. Sommarin Y., Wendel M., Shen Z., Hellman U., and Heinegard D. Osteoadherin, a cell-binding keratan sulfate proteoglycan in bone, belongs to the family of leucine-rich repeat proteins of the extracellular matrix. J. Biol. Chem. 273 (1998) 16723-16729
30. Gertow K., Wolbank S., Rozell B., Sugars R., Andang M., Parish C.L., Imreh M.P., Wendel M., and Ahrlund-Richter L. Organized development from human embryonic stem cells after injection into immunodeficient mice. Stem Cells Dev. 13 (2004) 421-435
31. Hunter G.K., Hauschka P.V., Poole A.R., Rosenberg L.C., and Goldberg H.A. Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem. J. 317 Pt 1 (1996) 59-64
32. Barberi T., Willis L.M., Socci N.D., and Studer L. Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med. 2 (2005) e161
33. Sato H., Takahashi M., Ise H., Yamada A., Hirose S., Tagawa Y., Morimoto H., Izawa A., and Ikeda U. Collagen synthesis is required for ascorbic acid-enhanced differentiation of mouse embryonic stem cells into cardiomyocytes. Biochem. Biophys. Res. Commun. 342 (2006) 107-112
34. Tsuneto M., Yamazaki H., Yoshino M., Yamada T., and Hayashi S. Ascorbic acid promotes osteoclastogenesis from embryonic stem cells. Biochem. Biophys. Res. Commun. 335 (2005) 1239-1246
35. Shin D.M., Ahn J.I., Lee K.H., Lee Y.S., and Lee Y.S. Ascorbic acid responsive genes during neuronal differentiation of embryonic stem cells. NeuroReport 15 (2004) 1959-1963
36. Srivastava A.S., Kaushal S., Mishra R., Lane T.A., and Carrier E. Dexamethasone facilitates erythropoiesis in murine embryonic stem cells differentiating into hematopoietic cells in vitro. Biochem. Biophys. Res. Commun. 346 (2006) 508-516
37. Darr H., Mayshar Y., and Benvenisty N. Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features. Development 133 (2006) 1193-1201
38. Kochupurakkal B.S., Sarig R., Fuchs O., Piestun D., Rechavi G., and Givol D. Nanog inhibits the switch of myogenic cells towards the osteogenic lineage. Biochem. Biophysi. Res. Commun. 365 (2008) 846-850
39. Go M.J., Takenaka C., and Ohgushi H. Forced expression of Sox2 or Nanog in human bone marrow derived mesenchymal stem cells maintains their expansion and differentiation capabilities. Exp. Cell Res. 314 (2008) 1147-1154
40. Purpura K.A., Aubin J.E., and Zandstra P.W. Sustained in vitro expansion of bone progenitors is cell density dependent. Stem Cells 22 (2004) 39-50
41. Reubinoff B.E., Pera M.F., Fong C.Y., Trounson A., and Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 18 (2000) 399-404
42. Nakashima K., and de Crombrugghe B. Transcriptional mechanisms in osteoblast differentiation and bone formation. Trends Genet. 19 (2003) 458-466
43. Rehn A.P., Chalk A.M., and Wendel M. Differential regulation of osteoadherin (OSAD) by TGF-beta1 and BMP-2. Biochem. Biophys. Res. Commun. 349 (2006) 1057-1064
44. Wendel M., Sommarin Y., and Heinegard D. Bone matrix proteins: isolation and characterization of a novel cell-binding keratan sulfate proteoglycan (osteoadherin) from bovine bone. J. Cell Biol. 141 (1998) 839-847
45. Ramstad V.E., Franzen A., Heinegard D., Wendel M., and Reinholt F.P. Ultrastructural distribution of osteoadherin in rat bone shows a pattern similar to that of bone sialoprotein. Calcif. Tissue Int. 72 (2003) 57-64
46. Rehn A.P., Cerny R., Sugars R.V., Kaukua N., and Wendel M. Osteoadherin (OSAD) is up-regulated by mature osteoblasts and enhances their in vitro differentiation and mineralisation. Calcif. Tissue Int. 82 (2008) 454-464
47. Liu F., Malaval L., Gupta A.K., and Aubin J.E. Simultaneous detection of multiple bone-related mRNAs and protein expression during osteoblast differentiation: polymerase chain reaction and immunocytochemical studies at the single cell level. Dev. Biol. 166 (1994) 220-234
48. Sodek J., Ganss B., and McKee M.D. Osteopontin. Crit. Rev. Oral Biol. Med. 11 (2000) 279-303
49. Nomura S., Wills A.J., Edwards D.R., Heath J.K., and Hogan B.L. Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J. Cell Biol. 106 (1988) 441-450
50. Zohar R., Lee W., Arora P., Cheifetz S., McCulloch C., and Sodek J. Single cell analysis of intracellular osteopontin in osteogenic cultures of fetal rat calvarial cells. J. Cell. Physiol. 170 (1997) 88-100
51. Zohar R., Suzuki N., Suzuki K., Arora P., Glogauer M., McCulloch C.A., and Sodek J. Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration. J. Cell. Physiol. 184 (2000) 118-130
52. Owen T.A., Aronow M., Shalhoub V., Barone L.M., Wilming L., Tassinari M.S., Kennedy M.B., Pockwinse S., Lian J.B., and Stein G.S. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J. Cell. Physiol. 143 (1990) 420-430
53. Stein G.S., and Lian J.B. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr. Rev. 14 (1993) 424-442
54. Yao K.L., Todescan Jr. R., and Sodek J. Temporal changes in matrix protein synthesis and mRNA expression during mineralized tissue formation by adult rat bone marrow cells in culture. J. Bone Miner. Res. 9 (1994) 231-240
55. Weber G.F., Ashkar S., Glimcher M.J., and Cantor H. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271 (1996) 509-512
56. Zohar R., Cheifetz S., McCulloch C.A., and Sodek J. Analysis of intracellular osteopontin as a marker of osteoblastic cell differentiation and mesenchymal cell migration. Eur. J. Oral Sci. 106 Suppl 1 (1998) 401-407
57. Romberg R.W., Werness P.G., Riggs B.L., and Mann K.G. Inhibition of hydroxyapatite crystal growth by bone-specific and other calcium-binding proteins. Biochemistry 25 (1986) 1176-1180
58. Hauschka P.V., and Wians Jr. F.H. Osteocalcin-hydroxyapatite interaction in the extracellular organic matrix of bone. Anat. Rec. 224 (1989) 180-188
59. Malaval L., Liu F., Roche P., and Aubin J.E. Kinetics of osteoprogenitor proliferation and osteoblast differentiation in vitro. J. Cell. Biochem. 74 (1999) 616-627
60. Candeliere G.A., Liu F., and Aubin J.E. Individual osteoblasts in the developing calvaria express different gene repertoires. Bone 28 (2001) 351-361
61. Ito S., Suzuki N., Kato S., Takahashi T., and Takagi M. Glucocorticoids induce the differentiation of a mesenchymal progenitor cell line, ROB-C26 into adipocytes and osteoblasts, but fail to induce terminal osteoblast differentiation. Bone 40 (2007) 84-92
62. Huang L., Teng X.Y., Cheng Y.Y., Lee K.M., and Kumta S.M. Expression of preosteoblast markers and Cbfa-1 and Osterix gene transcripts in stromal tumour cells of giant cell tumour of bone. Bone 34 (2004) 393-401
63. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., and Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246 (1989) 1306-1309
64. Millauer B., Wizigmann-Voos S., Schnurch H., Martinez R., Moller N.P., Risau W., and Ullrich A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72 (1993) 835-846
65. Mayr-Wohlfart U., Waltenberger J., Hausser H., Kessler S., Gunther K.P., Dehio C., Puhl W., and Brenner R.E. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 30 (2002) 472-477
66. Midy V., and Plouet J. Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochem. Biophys. Res. Commun. 199 (1994) 380-386
67. Maes C., Carmeliet P., Moermans K., Stockmans I., Smets N., Collen D., Bouillon R., and Carmeliet G. Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mech. Dev. 111 (2002) 61-73
68. Zelzer E., McLean W., Ng Y.S., Fukai N., Reginato A.M., Lovejoy S., D'Amore P.A., and Olsen B.R. Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 129 (2002) 1893-1904
69. Celil A.B., Hollinger J.O., and Campbell P.G. Osx transcriptional regulation is mediated by additional pathways to BMP2/Smad signaling. J. Cell. Biochem. 95 (2005) 518-528
70. Ge C., Xiao G., Jiang D., and Franceschi R.T. Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development. J. Cell Biol. 176 (2007) 709-718
71. Hu Y., Chan E., Wang S.X., and Li B. Activation of p38 mitogen-activated protein kinase is required for osteoblast differentiation. Endocrinology 144 (2003) 2068-2074
72. Wang X., Goh C.H., and Li B. p38 mitogen-activated protein kinase regulates osteoblast differentiation through osterix. Endocrinology 148 (2007) 1629-1637
73. Gille H., Kowalski J., Yu L., Chen H., Pisabarro M.T., Davis-Smyth T., and Ferrara N. A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3′-kinase activation and endothelial cell migration. Embo J. 19 (2000) 4064-4073
74. Gorski J.P. Is all bone the same? Distinctive distributions and properties of non-collagenous matrix proteins in lamellar vs. woven bone imply the existence of different underlying osteogenic mechanisms. Crit. Rev. Oral Biol. Med. 9 (1998) 201-223
75. Wan C., He Q., and Li G. Osteoclastogenesis in the nonadherent cell population of human bone marrow is inhibited by rhBMP-2 alone or together with rhVEGF. J. Orthop. Res. 24 (2006) 29-36